Treatment With Endovascular Intervention for STroke Patients With Existing Disability
University of Cincinnati
1,060 participants
Nov 16, 2023
OBSERVATIONAL
Conditions
Summary
TESTED will compare the risks and benefits of endovascular thrombectomy (EVT) to medical management (no EVT) in ischemic stroke patients who have a blockage in one of the large blood vessels in the brain and have a moderate-to-severe disability prior to their stroke.
Eligibility
Inclusion Criteria8
- Adult patients (≥18 years)
- Moderate-to-severe pre-stroke functional disability, defined as mRS 3-4, for at least 3 months prior to stroke onset
- Presenting to study hospital within 24 hours of last known well time
- Diagnosis of acute ischemic stroke
- Intracranial causative occlusion of the internal carotid artery or the M1 or dominant M2 segments of the middle cerebral artery visualized on the baseline CT(or MR) angiogram
- Presenting CT Alberta Stroke Program Early CT (ASPECT) score ≥3 or MRI ASPECT score ≥4
- Presenting NIH Stroke Scale score ≥6
- Informed consent from patient if competent or from legally authorized representative
Exclusion Criteria3
- Known diagnosis of a terminal cancer or terminal illness at the time of stroke
- Assessment of pre-stroke functional status cannot be performed during the hospital stay
- Pre-stroke disability deemed temporary in the investigator's opinion (for example, recovering from a general medical illness or traumatic bodily injury)
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients who receive endovascular stroke treatment when they are admitted into the hospital, as determined by their clinical care team. Endovascular stroke treatment consist of catheter-based treatment for the blood clot causing the acute ischemic stroke
Patients who receive MMM when they are admitted into the hospital, as determined by their clinical care team. MMM may involve any combination of the following: intravenous thrombolysis, antiplatelets, anti-hypertensives, cholesterol-lowering medications, and rehabilitative care. Specifically, this treatment does not involve endovascular stroke treatment.
Locations(19)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05911568